Acromegalic Uteropathy: Specific Uterine Ultrasound Findings in Female Patients
Authors:
- Irina StanoevichISIrina Stanoevich
- Aurika AsanovaAAAurika Asanova
- Svetlana VorotnikovaSVSvetlana Vorotnikova
- Andrey BelovABAndrey Belov
- Ekaterina GrezinaEGEkaterina Grezina
- Yulia FedorovaYFYulia Fedorova
- Ugljesa StanojevicUSUgljesa Stanojevic
- Larisa DzeranovaLDLarisa Dzeranova
- Ekaterina PigarovaEPEkaterina Pigarova
- Galina MelnichenkoGMGalina Melnichenko
- Natalya MokryshevaNMNatalya Mokrysheva
Open Access
- 23 March 2026
- journal article
- research article
- Published by MDPI AG in Diagnostics
- Vol. 16 (6) , 956
Abstract
Background/Objectives: Acromegaly is a systemic connective tissue disease driven by chronic growth hormone (GH) and insulin-like growth factor-1 (IGF-1) excess; yet, the female reproductive tract—especially the extracellular matrix (ECM)-rich cervix—has been poorly studied. We aimed to compare uterine and cervical morphology in women with acromegaly versus healthy controls and a gynecologic disease comparator, testing the hypothesis of selective cervical hypertrophy. Methods: We performed a retrospective case–control study of reproductive-age women who underwent pelvic ultrasound: acromegaly (n = 33), healthy controls (n = 45), and adenomyosis without acromegaly (n = 44). Uterine body measurements were obtained by TAUS/TVUS; cervical biometry was performed transvaginally in all cases. Volumes were estimated using the ellipsoid formula, and a uterus-to-cervix (U:C) volume ratio was calculated. Group differences were analyzed with Mann–Whitney tests and Bonferroni correction. Results: A total of 122 women were included. Uterine body length, width, AP size, and volume did not differ between acromegaly and either comparison group (all p-values non-significant). In contrast, cervical length, width, AP thickness, and volume were significantly higher in acromegaly than in healthy controls, with a corresponding reduction in the U:C volume ratio, indicating disproportionate cervical enlargement. Compared with adenomyosis, women with acromegaly again showed larger cervical width, AP thickness, and volume, together with altered U:C indices, whereas cervical length did not differ, suggesting a pattern not explained by nonspecific pelvic pathology. Conclusions: Women with acromegaly demonstrate a distinct uterine phenotype characterized by selective cervical hypertrophy with preserved uterine corpus size—an ECM-centric “acromegalic uteropathy.” This noninvasive morphometric signature may have diagnostic and procedural relevance and warrants confirmation in prospective studies.Keywords
All Related Versions
This publication has 31 references indexed in Scilit:
- Grading Sonographic Severity of AdenomyosisJournal of Ultrasound in Medicine, 2024
- AIUM Practice Parameter for the Performance of Ultrasound of the Female Pelvis, 2024 RevisionJournal of Ultrasound in Medicine, 2024
- Uterine fibroids in women diagnosed with acromegaly: a systematic reviewReviews in Endocrine and Metabolic Disorders, 2024
- Consensus on criteria for acromegaly diagnosis and remissionPituitary, 2023
- Bioengineering and the cervix: The past, current, and future for addressing preterm birthCurrent Research in Physiology, 2023
- ISUOGPractice Guidelines: role of ultrasound in the prediction of spontaneous preterm birthUltrasound in Obstetrics & Gynecology, 2022
- Consensus on revised definitions of Morphological Uterus Sonographic Assessment (MUSA) features of adenomyosis: results of modified Delphi procedureUltrasound in Obstetrics & Gynecology, 2022
- Acromegaly and pregnancy: a systematic review and meta-analysisPituitary, 2022
- A Pituitary Society update to acromegaly management guidelinesPituitary, 2020
- Importance of embryo transfer technique in maximizing assisted reproductive outcomesFertility and Sterility, 2016